Question 1

What does Molbio Diagnostics Limited do?

Accepted Answer

Molbio Diagnostics Limited provides molecular diagnostic solutions and instruments. The company generates revenue by selling diagnostic products, instruments, and consumables to healthcare markets. Price band ₹768.00-₹807.00; issue size ₹939.70 cr.

Question 2

When does the Molbio Diagnostics Limited IPO open and close?

Accepted Answer

The Molbio Diagnostics Limited IPO opens for subscription on August 10, 2026 and closes on August 12, 2026. Shares are expected to list on August 17, 2026.

Question 3

What is the issue price of the Molbio Diagnostics Limited IPO?

Accepted Answer

The Molbio Diagnostics Limited IPO was priced at ₹807 per equity share.

Question 4

What is the lot size for the Molbio Diagnostics Limited IPO?

Accepted Answer

The lot size is 18 equity shares. At ₹807 per share, one lot requires ₹14,526.

Question 5

What is the issue size of the Molbio Diagnostics Limited IPO?

Accepted Answer

The total issue size is ₹939.70 crore. This comprises a fresh issue of ₹200.00 crore, which the company receives, and an offer for sale of ₹739.70 crore, which goes to selling shareholders.

Question 6

How did Molbio Diagnostics Limited perform on listing?

Accepted Answer

Molbio Diagnostics Limited opened at ₹980 against an issue price of ₹807, a premium of 21.44% on debut.

Question 7

Who are the lead managers for the Molbio Diagnostics Limited IPO?

Accepted Answer

The book running lead managers are Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited, Jefferies India Private Limited and Motilal Oswal Investment Advisors Limited. The registrar to the issue is KFin Technologies Limited.

Company
Molbio Diagnostics LimitedThis Issue	—	₹1.45K Cr	₹14.77	—	—
Poly Medicure Limited	52.61x	₹1.88K Cr	₹31.75	₹306.45	10.37%
Dr. Lal Pathlabs Limited	62.20x	₹2.76K Cr	₹30.20	₹145.00	20.78%
Metropolis Healthcare Limited	63.72x	₹1.65K Cr	₹9.19	₹72.98	12.56%
Vijaya Diagnostics Centre Limited	81.02x	₹814.20 Cr	₹16.79	₹93.02	18.07%

Molbio Diagnostics Limited

Issue Timeline & Lifecycle

Subscription Demand

Fundamentals & Key Metrics

Valuation & Multiples

Profitability & Returns

Financial Health & Solvency

Financials at a glance

Shareholding, Ownership & Dilution

Disclosed Pre-Offer Shareholders Table

AI Summary

Prospectus Research

Issue intermediaries

Listed Peer Valuation & Returns

Official Prospectus Filings

Frequently Asked Questions